Skip to main content

News

Medtech Top 20 Logo

OncoBeta® GmbH is listed as one of the Top 20 MedTech Outlook Solution Providers in Europe

OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers…

Read more

First Non-Melanocytic Skin Cancer Patients treated with Rhenium-SCT in South Africa

University of Pretoria Prof. Mike Sathekge is First in South Africa to Treat Non-Melanocytic Skin Cancer Patients with Rhenium-SCT®

 

OncoBeta® GmbH,…

Read more
South African Flag overlayed with the release title

OncoBeta’s Rhenium-SCT® for Non-Melanoma Skin Cancer to start in South Africa

TAUTOMER / NATIVA the official Rhenium-SCT® (Skin Cancer Therapy) Distributor for Continental Africa

 

OncoBeta GmbH®, a commercial stage Medical…

Read more
Map Medical Technologies Logo

OncoBeta GmbH® Announces Certification of its New Production Facility Partner MAP Medical Technologies Oy, Tikkakoski FINLAND

OncoBeta GmbH has today announced the certification of its new production facility partner MAP Medical Technologies Oy, Tikkakoski FINLAND, aiming to…

Read more
OncoBeta GmbH Coorporate Logo

Rhenium-SCT® (Skin Cancer Therapy) now being offered in Bologna, Italy

Created by Shannon Brown |

OncoBeta® GmbH is privileged to announce the start of the next Rhenium-SCT® treatment center located in Bologna Italy.

Read more